These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12646625)

  • 1. The molecular basis for the lack of immunostimulatory activity of vertebrate DNA.
    Stacey KJ; Young GR; Clark F; Sester DP; Roberts TL; Naik S; Sweet MJ; Hume DA
    J Immunol; 2003 Apr; 170(7):3614-20. PubMed ID: 12646625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of suppressive DNA on CpG-induced immune activation.
    Yamada H; Gursel I; Takeshita F; Conover J; Ishii KJ; Gursel M; Takeshita S; Klinman DM
    J Immunol; 2002 Nov; 169(10):5590-4. PubMed ID: 12421936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial DNA containing methylated CpG motifs retains immunostimulatory activity in synergy with modified lipopolysaccharides.
    Cho YJ; Ahn BY; Song ES; Park SA; Lee DH; Kim DS; Lee NG
    Microbiol Immunol; 2007; 51(2):211-22. PubMed ID: 17310089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides.
    Krieg AM
    Biochim Biophys Acta; 1999 Dec; 1489(1):107-16. PubMed ID: 10807001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorothioate backbone modification modulates macrophage activation by CpG DNA.
    Sester DP; Naik S; Beasley SJ; Hume DA; Stacey KJ
    J Immunol; 2000 Oct; 165(8):4165-73. PubMed ID: 11035048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG-containing oligodeoxynucleotides induce TNF-alpha and IL-6 production but not degranulation from murine bone marrow-derived mast cells.
    Zhu FG; Marshall JS
    J Leukoc Biol; 2001 Feb; 69(2):253-62. PubMed ID: 11272276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunostimulatory CpG-DNA activates murine microglia.
    Dalpke AH; Schäfer MK; Frey M; Zimmermann S; Tebbe J; Weihe E; Heeg K
    J Immunol; 2002 May; 168(10):4854-63. PubMed ID: 11994434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of immunostimulatory oligodeoxynucleotide from Escherichia coli genomic DNA.
    Choi YJ; Lee KW; Kwon HJ; Kim DS
    J Biochem Mol Biol; 2006 Nov; 39(6):788-93. PubMed ID: 17129417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in macrophage activation by bacterial DNA and CpG-containing oligonucleotides.
    Roberts TL; Dunn JA; Terry TD; Jennings MP; Hume DA; Sweet MJ; Stacey KJ
    J Immunol; 2005 Sep; 175(6):3569-76. PubMed ID: 16148100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunostimulatory oligodeoxynucleotide isolated from genome wide screening of Mycobacterium bovis chromosomal DNA.
    Lee KW; Jung J; Lee Y; Kim TY; Choi SY; Park J; Kim DS; Kwon HJ
    Mol Immunol; 2006 May; 43(13):2107-18. PubMed ID: 16442622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of immunostimulatory CpG-rich sequences from different Bifidobacterium species.
    Ménard O; Gafa V; Kapel N; Rodriguez B; Butel MJ; Waligora-Dupriet AJ
    Appl Environ Microbiol; 2010 May; 76(9):2846-55. PubMed ID: 20208019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct immunologic activities of CpG DNA and implications for gene therapy.
    Krieg AM
    J Gene Med; 1999; 1(1):56-63. PubMed ID: 10738585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds.
    Macfarlane DE; Manzel L
    J Immunol; 1998 Feb; 160(3):1122-31. PubMed ID: 9570525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA and its cationic lipid complexes induce CpG motif-dependent activation of murine dendritic cells.
    Yoshinaga T; Yasuda K; Ogawa Y; Nishikawa M; Takakura Y
    Immunology; 2007 Mar; 120(3):295-302. PubMed ID: 17199803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactoferrin binds CpG-containing oligonucleotides and inhibits their immunostimulatory effects on human B cells.
    Britigan BE; Lewis TS; Waldschmidt M; McCormick ML; Krieg AM
    J Immunol; 2001 Sep; 167(5):2921-8. PubMed ID: 11509640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirements for effective inhibition of immunostimulatory CpG motifs by neutralizing motifs.
    Zhao H; Cheng SH; Yew NS
    Antisense Nucleic Acid Drug Dev; 2000 Oct; 10(5):381-9. PubMed ID: 11079577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG oligodeoxynucleotides as DNA adjuvants in vertebrates and their applications in immunotherapy.
    Chaung HC
    Int Immunopharmacol; 2006 Oct; 6(10):1586-96. PubMed ID: 16919831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs.
    Chen Y; Lenert P; Weeratna R; McCluskie M; Wu T; Davis HL; Krieg AM
    Gene Ther; 2001 Jul; 8(13):1024-32. PubMed ID: 11438837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells.
    Bauer M; Redecke V; Ellwart JW; Scherer B; Kremer JP; Wagner H; Lipford GB
    J Immunol; 2001 Apr; 166(8):5000-7. PubMed ID: 11290780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of interleukin-6 and interleukin-12 in bovine B lymphocytes, monocytes, and macrophages by a CpG oligodeoxynucleotide (ODN 2059) containing the GTCGTT motif.
    Zhang Y; Shoda LK; Brayton KA; Estes DM; Palmer GH; Brown WC
    J Interferon Cytokine Res; 2001 Oct; 21(10):871-81. PubMed ID: 11711000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.